Financial results first quarter 2019

VaxThera, a SURA Company Created in Colombia for the Research and Development of Vaccines for Latin America Grupo SURA 29 · June · 2021

Grupo SURA's consolidated earnings at the end of Q1 2021 showed a recovery on the part of our portfolio companies along with a good deal of progress made by our subsidiaries in the face of the current pandemic Grupo SURA 14 · May · 2021

SURA Asset Management reaffirms its commitment to sustainable investment with the aim of ensuring a brighter future SURA AM 14 · April · 2021